Using smartwatches to detect early signs of Alzheimer's disease
Digital phenotypes from a low-cost smartwatch to inform early detection of Alzheimer's disease and related dementias
This study is looking at how affordable smartwatches can help keep track of daily habits and health signs in people aged 55 and older to spot early signs of Alzheimer's and related dementias, making it easier to catch changes in thinking and memory.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10995615 on NIH RePORTER |
What this research studies
This research investigates how low-cost smartwatches can be used to monitor daily behaviors and physiological metrics to identify early signs of Alzheimer's disease and related dementias. Participants aged 55 and older will wear a smartwatch continuously to collect data on sleep patterns, heart rate, and other metrics. The study aims to compare these smartwatch-derived metrics with traditional neuropsychological assessments to evaluate their effectiveness in detecting cognitive changes. By utilizing technology that is accessible and non-invasive, the research seeks to provide a more practical approach to early detection of dementia.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 55 and older who have either healthy cognition or mild cognitive impairment.
Not a fit: Patients with advanced Alzheimer's disease or those under 55 years of age may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of Alzheimer's disease, allowing for timely interventions and better management of the condition.
How similar studies have performed: Previous research has shown promise in using digital phenotyping for monitoring cognitive health, indicating that this approach could be effective.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Holmqvist, Sophia — Temple Univ of the Commonwealth
- Study coordinator: Holmqvist, Sophia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.